12 April 2024
The Evers company has registered a new medical product: an ointment mesh sterile dressing for wound healing. Production of this product has already commenced at the company’s facility, with a staggering target of manufacturing 40,000 units monthly.
As specified, investments in the project amounted to 11 million rubles. The bandage is an atraumatic rectangular polyester mesh impregnated with a medicinal ointment composition. It is based on copper and zinc. The mesh is designed to fit any complex wound, without adhering to the wound surface and without causing any discomfort when removed or replaced. It is noted that the ointment base of the dressing prevents the entry of microorganisms.
PrintMerry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
17 new drugs added to the list of vital and essential drugs
23 January 2025
Sechenov University has opened its Representative Office in Hangzhou (China)
23 January 2025
A Moscow region manufacturer of blood collection systems is expanding its capacity
22 January 2025
A biotechnology and medicine center has opened in Mordovia
22 January 2025